Thymur Chaudhry, MD
Neuroradiology · Sacramento, CANPI 1043660285
Payments from drug & device makers
What this record shows
This record is dominated by grants: $25,000 of the $35,919 with a category attached, or 69.6%. Medtronic accounts for 79.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $26,415 and has fallen 98.5% since, to $385 in 2025.
Across 74 payments — averaging $485.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$29K
- Penumbra, Inc.$4K
- Balt USA, LLC$1K
- Stryker$957
- Microvention, Inc.$353
- Medical Device Business Services, Inc.$287
- plus $278 from 2 others
What the payments were for
- Speaking & faculty fees$1160%
- Grants$25,00070%
- Travel & lodging$8,10823%
- Food & beverage$2,6917%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 35 | $28,682 |
| Penumbra, Inc. | 14 | $3,984 |
| Balt USA, LLC | 5 | $1,379 |
| Stryker | 5 | $957 |
| Microvention, Inc. | 4 | $353 |
| Medical Device Business Services, Inc. | 6 | $287 |
| Route 92 Medical, Inc. | 2 | $179 |
| Imperative Care, Inc | 3 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NAVIENTM$25,000
- Pipeline$2,755
- Penumbra System$2,320
- Smart Coil$1,532
- EVOLVE$899
- Eclipse 2L$812
- WEB Aneurysm Embolization System$304
- Ballast 088 Long Sheath$277
- Prestige Coil System$177
- SOLITAIRE X$175
- STENT$148
- SOFIA 6F-131CM STR$148
- CEREPAK UNIFORM$146
- TRUFILL$146
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$146
- Embotrap$146
How this compares
$35,919 in reported general payments places this provider in the 85th percentile of 154 neuroradiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 24 | $111 |
Paid to pharmacies, not to this prescriber.
Other neuroradiology in Sacramento
- Bahram VarjavandSacramento$5K
- Jonathan HartmanSacramento$5K
- Lotfi Hacein-BeySacramento$4K
- Matthew BobinskiSacramento$3K
- Azad GhassemiSacramento$1K
- Aaron BerezMountain View$24.1M
- Amon LiuRedwood City$1.1M
- Fabio SettecaseSan Francisco$758K
- Michael MarksStanford$254K
- Huy DoStanford$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.